Evidence map›Paper›PMID 26646013›Full record

ArticlemBio2015

Structural Insight into How Bacteria Prevent Interference between Multiple Divergent Type IV Secretion Systems.

Joseph J Gillespie, Isabelle Q H Phan, Holger Scheib, Sandhya Subramanian, Thomas E Edwards, Stephanie S Lehman, Hanna Piitulainen, M Sayeedur Rahman, Kristen E Rennoll-Bankert, Bart L Staker and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. mSphere · 2023
    Article
  6. bioRxiv : the preprint server for biology · 2023
    Article
  7. Metagenome diversity illuminates origins of pathogen effectors.bioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Bacteria-Killing Type IV Secretion Systems.Frontiers in microbiology · 2019
    Review
  14. VirB8 homolog TraE from plasmid pKM101 forms a hexameric ring structure and interacts with the VirB6 homolog TraD.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  15. Molecular Mechanisms ofFrontiers in cellular and infection microbiology · 2018
    Review
  16. Article
  17. Article
  18. Comparative Pan-Genome Analysis ofFrontiers in cellular and infection microbiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Joseph J GillespieDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA JGillespie@som.umaryland.edu arto.pulliainen@utu.fi.
Isabelle Q H PhanSeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA The Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA.
Holger ScheibVenom Evolution Lab, School of Biological Sciences, University of Queensland, St. Lucia, Queensland, Australia.
Sandhya SubramanianSeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA The Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA.
Thomas E EdwardsSeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA Beryllium Discovery Corp., Bainbridge Island, Washington, USA.
Stephanie S LehmanDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Hanna PiitulainenDepartment of Biosciences, University of Helsinki, Helsinki, Finland.
M Sayeedur RahmanDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kristen E Rennoll-BankertDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Bart L StakerSeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA The Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA.
Suvi TairaDepartment of Biosciences, University of Helsinki, Helsinki, Finland.
Robin StacySeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA The Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA.
Peter J MylerSeattle Structural Genomics Center for Infectious Disease, Seattle, Washington, USA The Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA.
Abdu F AzadDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Arto T PulliainenDepartment of Biosciences, University of Helsinki, Helsinki, Finland Institute of Biomedicine, University of Turku, Turku, Finland JGillespie@som.umaryland.edu arto.pulliainen@utu.fi.
Center for Infectious Disease Research · USUniversity of Maryland, Baltimore · USUniversity of Helsinki · FIBeryllium (United States) · USUniversity of Queensland · AU

Funding

MURINE TYPHUS: VECTOR BIOLOGY AND TRANSMISSIONR01AI017828 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI RAHMAN, MOHAMMED SAYEEDUR · 1985 to 2022
$10.2M
Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
INTERSPECIFIC COMPETITION BETWEEN RICKETTSIAE IN TICKSR01AI043006 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI AZAD, ABDU F · 1998 to 2014
$3.3M
IMMUNITY AND INFECTIONT32AI007540 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 1998 to 2018
$2.2M
Generation of Genetically Attenuated RickettsiaeR01AI059118 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI AZAD, ABDU F · 2005 to 2009
$2.1M
NIAID NIH HHS HHSN272200700057CNIAID NIH HHS HHSN272201200025CNIAID NIH HHS R01 AI017828NIAID NIH HHS R01AI017828NIAID NIH HHS R01 AI043006NIAID NIH HHS R01AI043006NIAID NIH HHS R01 AI059118NIAID NIH HHS R01AI59118NIAID NIH HHS T32 AI007540NIAID NIH HHS T32AI007540NIAID NIH HHS T32 AI095190NIAID NIH HHS T32AI095190PHS HHS HHSN272200700057CPHS HHS HHSN272201200025C
6 · The paper itself

Abstract

unlabelledProkaryotes use type IV secretion systems (T4SSs) to translocate substrates (e.g., nucleoprotein, DNA, and protein) and/or elaborate surface structures (i.e., pili or adhesins). Bacterial genomes may encode multiple T4SSs, e.g., there are three functionally divergent T4SSs in some Bartonella species (vir, vbh, and trw). In a unique case, most rickettsial species encode a T4SS (rvh) enriched with gene duplication. Within single genomes, the evolutionary and functional implications of cross-system interchangeability of analogous T4SS protein components remains poorly understood. To lend insight into cross-system interchangeability, we analyzed the VirB8 family of T4SS channel proteins. Crystal structures of three VirB8 and two TrwG Bartonella proteins revealed highly conserved C-terminal periplasmic domain folds and dimerization interfaces, despite tremendous sequence divergence. This implies remarkable structural constraints for VirB8 components in the assembly of a functional T4SS. VirB8/TrwG heterodimers, determined via bacterial two-hybrid assays and molecular modeling, indicate that differential expression of trw and vir systems is the likely barrier to VirB8-TrwG interchangeability. We also determined the crystal structure of Rickettsia typhi RvhB8-II and modeled its coexpressed divergent paralog RvhB8-I. Remarkably, while RvhB8-I dimerizes and is structurally similar to other VirB8 proteins, the RvhB8-II dimer interface deviates substantially from other VirB8 structures, potentially preventing RvhB8-I/RvhB8-II heterodimerization. For the rvh T4SS, the evolution of divergent VirB8 paralogs implies a functional diversification that is unknown in other T4SSs. Collectively, our data identify two different constraints (spatiotemporal for Bartonella trw and vir T4SSs and structural for rvh T4SSs) that mediate the functionality of multiple divergent T4SSs within a single bacterium. IMPORTANCE: Assembly of multiprotein complexes at the right time and at the right cellular location is a fundamentally important task for any organism. In this respect, bacteria that express multiple analogous type IV secretion systems (T4SSs), each composed of around 12 different components, face an overwhelming complexity. Our work here presents the first structural investigation on factors regulating the maintenance of multiple T4SSs within a single bacterium. The structural data imply that the T4SS-expressing bacteria rely on two strategies to prevent cross-system interchangeability: (i) tight temporal regulation of expression or (ii) rapid diversification of the T4SS components. T4SSs are ideal drug targets provided that no analogous counterparts are known from eukaryotes. Drugs targeting the barriers to cross-system interchangeability (i.e., regulators) could dysregulate the structural and functional independence of discrete systems, potentially creating interference that prevents their efficient coordination throughout bacterial infection.

Indexed as

BartonellaCrystallography, X-RayModels, MolecularProtein BindingProtein ConformationProtein MultimerizationRickettsia typhiSubstrate SpecificityTwo-Hybrid System TechniquesType IV Secretion SystemsType IV Secretion Systems

Identifiers

PMID26646013
PMCPMC4676284
OpenAlexW2194597461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.